Tradestie Institutional Equity Comparison Engine

CTKB vs MYO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CTKB Overall Edge

CTKB Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cytek Biosciences, Inc. Common Stock (CTKB) driven by superior Momentum & Technical, Options & Structure while MYO counters with relative strength in Growth & Margin. Fundamentally, CTKB trades at N/M Forward P/E with -22.5% operating margin (+1.8% YoY revenue) versus MYO at N/M Forward P/E and -21.8% operating margin (+22.2% YoY). In options structure, CTKB sits in CONSOLIDATION (<1st %ile IV; Dealer Gamma Walls on Pro) against MYO sits in UNCLASSIFIED (81st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CTKB N/M vs MYO N/M Fwd P/E
Growth & Margin Winner MYO
Op Margin -22.5% vs -21.8% ยท YoY +1.8% vs +22.2%
Momentum & Technical Winner CTKB
1Y +16.4% vs +12.3% ยท 52W Pos 91% vs 16%
Options & Structure Winner CTKB
CONSOLIDATION (<1st %ile IV) vs UNCLASSIFIED (81st %ile IV)
CTKB NASDAQ
Cytek Biosciences, Inc. Common Stock
Laboratory Analytical Instruments
$6.12
-3.16% 1D
Market Cap $826.6M
1M Return +12.71%
1Y Return +16.35%
Forward P/E N/M
Unified AI Score
48.4 / 100 HOLD
Tech 33.0 Fund 44.0 Flow 60.0 Mom 41.1
MYO NYSE American
Myomo Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.81
-3.45% 1D
Market Cap $33.7M
1M Return -33.52%
1Y Return +12.3%
Forward P/E N/M
Unified AI Score
40.1 / 100 SELL
Tech 25.0 Fund 43.0 Flow 58.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CTKB +16.35% MYO +12.3% Spread: +4.05 pp (CTKB Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CTKB Revenue MYO Revenue CTKB Op. Margin MYO Op. Margin Margin Edge
FY2018 N/A $0M N/A -430.8% MYO
FY2019 N/A $0M N/A -281.3% MYO
FY2020 $90M $10M 14.7% -138.5% CTKB
FY2021 $130M $10M 7.2% -74.1% CTKB
FY2022 $160M $20M -1.1% -68.6% CTKB
FY2023 $190M $20M -14.4% -42.8% CTKB
FY2024 $200M $30M -10.2% -19.1% CTKB
FY2025 $200M $40M -20.0% -35.2% CTKB

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CTKB (5) vs MYO (3)
Institutional Metric CTKB MYO Criterion Row Winner
Market Capitalization Scale $826.6M $33.7M Larger Scale CTKB
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +1.8% +22.2% Higher Growth MYO
Operating Margin (TTM) Profitability -22.5% -21.8% Higher Margin MYO
Net Profit Margin Profitability -39.1% -33.1% Higher Margin MYO
Return on Equity (ROE) Capital Efficiency -23.2% -173.5% Higher ROE CTKB
52-Week Range Position Momentum 91% ($3โ€“$6) 16% ($1โ€“$2) Stronger Trend CTKB
Beta / 30D Volatility Risk Regime 0.71ฮฒ ยท 67% Vol 2.22ฮฒ ยท 107% Vol Lower Realized Risk CTKB
Unified Institutional Score Composite Signal 48.4 / 100 (HOLD) 40.1 / 100 (SELL) Higher Composite CTKB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CTKB vs MYO Buy Guide
CTKB CONSOLIDATION
16d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live CTKB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MYO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 81st %ile
IV Regime Extreme (>80th %ile)
Live MYO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CTKB nor MYO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.